Science· 2018Q1
Cancer immunotherapy using checkpoint blockade
- 6,782citations
- Q1SCImago
- 2018year
Short summary
Blocking immune checkpoints like CTLA-4 and PD-1 with antibodies elicits long-lasting tumor responses in many cancer patients by releasing negative regulators of immune activation.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Oncology
OncologyMedicine